✦ LIBER ✦

Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients

✍ Scribed by Ajay Israni; Susan Brozena; Oleh Pankewycz; Robert Grossman; Roy Bloom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Comparison of Tacrolimus- and

✍ Robert F. English; Stephen A. Pophal; Silviu-Alin Bacanu; Jay Fricker; Gerard J. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Pharmacodynamic Monitoring of the Conver

✍ M.J. Barten; A. Rahmel; J. Garbade; A. Bold; H.B. Bittner; S. Dhein; F.W. Mohr; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Treatment of tacrolimus-related adverse

✍ Sukru Emre; Yuri Genyk; Leona Kim Schluger; Thomas M. Fishbein; Stephen R. Guy; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 599 KB

Treatment of tacrolimus-related adverse

✍ S. Emre; Y. Genyk; L. K. Schluger; T. M. Fishbein; S. R. Guy; P. A. Sheiner; M. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 63 KB

Improvement of Nephrotoxicity, Hypertens

✍ S Friemann; E Feuring; W Padberg; W Ernst 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Conversion to Tacrolimus and Atorvastati

✍ Blanka Skalicka; Milos Kubanek; Ivan Malek; Yevheniya Vymetalova; Lenka Hoskova; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 373 KB